Addex Therapeutics (ADXN) Operating Margin (2022 - 2025)
Historic Operating Margin for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 2342.13%.
- Addex Therapeutics' Operating Margin fell 11864200.0% to 2342.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 4217.87%, marking a year-over-year decrease of 34010700.0%. This contributed to the annual value of 681.82% for FY2024, which is 5427600.0% down from last year.
- Per Addex Therapeutics' latest filing, its Operating Margin stood at 2342.13% for Q3 2025, which was down 11864200.0% from 12575.46% recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Operating Margin registered a high of 12575.46% during Q2 2025, and its lowest value of 182692.31% during Q4 2024.
- Its 4-year average for Operating Margin is 12534.09%, with a median of 1017.78% in 2022.
- In the last 5 years, Addex Therapeutics' Operating Margin crashed by -1812306000bps in 2024 and then surged by 133574800bps in 2025.
- Over the past 4 years, Addex Therapeutics' Operating Margin (Quarter) stood at 3463.7% in 2022, then skyrocketed by 58bps to 1461.7% in 2023, then plummeted by -12399bps to 182692.31% in 2024, then soared by 99bps to 2342.13% in 2025.
- Its Operating Margin was 2342.13% in Q3 2025, compared to 12575.46% in Q2 2025 and 672.09% in Q1 2025.